// App-Quantinova.ai

1655 : Belimumab Disrupts Memory B-Cell Trafficking in Patients with Systemic Lupus Erythematosus

Researchers

Presenter

  • Onno Teng

Principal Investigators

  • Eline J. Arends

  • Mihaela Zlei

  • Christopher M. Tipton

  • Jasna Cotic

  • Zgjim Osmani

  • Fenna J. De Bie

  • Sylvia W.A. Kamerling

  • Andre Van Maurik

  • Richard Dimelow

  • Yun Irene Gregan

  • Norma Lynn Fox

  • Ton J. Rabelink

  • David A. Roth

  • Iñaki Sanz

  • Jacques J.M. Van Dongen

  • Cees Van Kooten

Medical Centers

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Department of Urology, Leiden Unviersity Medical Center, Leiden, Netherlands

  • Lowance Center for Human Immunology, Emory University School of Medicine, Atlanta, GA

  • Clinical Statistics, GlaxoSmithKline, Stevenage, United Kingdom,

  • GlaxoSmithKline, Clinical Pharmacology and Experimental Medicine, Stevenage, United Kingdom

  • GlaxoSmithKline, Clinical Biomarker Group, Stevenage, United Kingdom

  • GlaxoSmithKline, Clinical Science Immunology, Rockville, MD

  • GlaxoSmithKline, Clinical Development *At time of study, Collegeville, PA

  • GlaxoSmithKline Research and Development, Collegeville, PA

  • Emory University, Atlanta, GA

  • Leiden University Medical Centre, Leiden, Netherlands

Locations

  • United Kingdom

  • Panama

  • Netherlands

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Belimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • N/A

Study Id's

  • NCT00071487

  • NCT00410384

  • NCT01632241

  • NCT01649765

  • NCT03747159]

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved